Elago, Margaux Candice .

HRN: 15-76-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
CEFUROXIME 750MG (VIAL)
02/03/2024
02/09/2024
IV
730mg
Q8h
URTI
Checking Final Appropriateness 
02/04/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
02/04/2024
02/10/2024
PO
6.5ml
BID
URTI
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: